Quick Search:         Advanced Search
Chinese Version
Online office
Journal Online
Download
Top
Links
朱辟疆,李雨生.保元强肾Ⅰ号片延长终末期肾病血透间期研究[J].,1996,(6):326-329
保元强肾Ⅰ号片延长终末期肾病血透间期研究
Study on Effect of Baoyuan Qiangshen Tablet No.Ⅰin Prolongating Interval of Hemodialysis in Patients of Terminal-Stage of Renal Disease
  
DOI:
中文关键词:  终末期肾病  保元强肾Ⅰ号片  血液透析
英文关键词:terminal-stage of renal disease  Baoyuan Qiangshen tablet No.Ⅰ  hemodialysis
基金项目:
Author NameAffiliation
朱辟疆 江苏省中西医结合肾病研究中心 
李雨生 江苏省中西医结合肾病研究中心 
Hits: 1288
Download times: 1025
中文摘要:
      对20例终末期肾病(TSRD)患者,采用保元强肾Ⅰ号片联合5天1次血液透析(血透)的中西医结合治疗组(中西组),并与3天1次的常规血透组(对照组)比较,结果中西组血透间期SCr、BUN上升幅度显著低于对照组(P<0.01),经3个月治疗后,中西组SCr、BUN均比治前明显降低(P<0.01),但CCr治疗前后无显著差异(P>0.05)。血浆白蛋白、脂蛋白、尿前列腺素及贫血均有不同程度改善。提示保元强肾Ⅰ号片可能通过调整脂质紊乱,延长慢性肾衰的进展,保护残余肾单位功能,从而起到延长血透间期,减少血透次数的作用。
英文摘要:
      Twenty cases of terminal stage of renal disease(TSRD) were treated with Baoyuan Qiangshen Tablet No.Ⅰ(BYQS Ⅰ) combined with hemodialysis once every 5 days(TCM-WM group) was observed and compared with patients treated with routine hemodialysis(once every 3 days) only(control group).Results showed that the increaseing extents of serum creatinine,blood urea nitrogen of TCM-WM group at dialysis interval were all lower than that of control group(p<0.01).After 3 months,treatment,serum creatinine,blood urea nitrogen of TCM-WM group were lower than that before treatment,plasma albumin,lipoprotein, urine level of prostaglandin and anemia were all improved to varies extent,but the creatinine clearance rate was unchanged.The author considered that BYQS Ⅰ could prolong the interval and reduce the times of dialysis by way of regulating the lipid metabolism disorder,improving pathological change of kidney and protect function of residual kidney unit, and above-mentioned therapeutic method is a good programm of integrated TCM-WM in treating TSRD.
View Full Text  View/Add Comment  Download reader